About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

21

Sep

2017

CVS Caremark®: Kentucky MAC Notification

In accordance with Kentucky MAC law (Ky.Rev.Stat.Ann. §304.17A-162), the following is a list of products for which CVS CaremarkTM MAC adjustments have been made with retroactive effective dates as a result of granted MAC appeals.

21

Sep

2017

OptumRx: Hurricane Maria Notice to ALL Pharmacies

This notice is intended to assist in providing direction from OptumRx related to Hurricane Maria.

19

Sep

2017

Blue Cross and Blue Shield of Illinios and New Mexico - Medicaid Formulary Update

Effective September 1, 2017

Effective September 1, 2017, there will be a change in formulary status for preferred pen needle products for Covered Persons of Blue Cross Blue Shield of Illinois and New Mexico Medicaid. Please see the attachment below for further processing instructions.

19

Sep

2017

PerformRX : AmeriHealth Caritas Iowa - Changes to the Medicaid Preferred Drug List

Effective October 1, 2017

Effective October 1, 2017, the following changes will be made to the PDL and pharmacy prior authorization criteria.

19

Sep

2017

OptumRx: Recall of Infusion Sets by Medtronic

Effective September 12th 2017

On September 12, 2017, the FDA announced a voluntary recall of some lots of Medtronic infusion sets because a discontinued component, the vent membrane, may be susceptible to being blocked by fluid during the process of priming/fill-tubing, leading to over-delivery of insulin shortly after an infusion set change, resulting in potential hypoglycemia.
First 357358359360 Last